Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses AGL in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named AGL in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Steven Sell | $431,507 | $0 | $4,050,004 | $2,250,001 | $0 | $0 | $546,875 | $7,278,387 |
| Former Chief Executive Officer and President | ||||||||
| Jeffrey Schwaneke | 625,000 | 0 | 2,950,003 | 1,750,000 | 271,875 | 0 | 14,000 | 5,610,878 |
| Chief Financial Officer and Interim Co-Principal Executive Officer | ||||||||
| Benjamin Shaker | 450,000 | 0 | 2,950,003 | 1,750,000 | 193,545 | 0 | 14,000 | 5,357,548 |
| Chief Markets Officer and Interim Co-Principal Executive Officer | ||||||||
| Denise Zamore | 425,000 | 0 | 1,500,008 | 1,000,002 | 184,408 | 0 | 14,000 | 3,123,418 |
| Chief Legal Officer and Corporate Secretary | ||||||||
| Girish Venkatachaliah | 425,000 | 0 | 937,506 | 500,001 | 184,875 | 0 | 8,704 | 2,056,086 |
| Chief Technology Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Steven Sell | $7,278,387 | $5,416,043 | $5,267,036 | +1,862,344 |
| Jeffrey Schwaneke | 5,610,878 | 7,136,122 | — | −1,525,244 |
| Benjamin Shaker | 5,357,548 | 4,102,777 | 2,930,218 | +1,254,771 |
| Denise Zamore | 3,123,418 | — | — | — |
| Girish Venkatachaliah | 2,056,086 | 2,560,893 | 2,880,218 | −504,807 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Jeffrey Schwaneke | PSU | 2025-04-01 | 11,764 | 11,764 | — | 47,056 | $1,200,001 |
| Benjamin Shaker | PSU | 2025-04-01 | 11,764 | 11,764 | — | 47,056 | 1,200,001 |
| Benjamin Shaker | PSU | 2025-04-01 | — | 26,923 | — | 102 | 1,750,000 |
| Denise Zamore | RSU | 2025-04-01 | — | — | 9,803 | — | 1,000,004 |
| Steven Sell | PSU | 2025-04-01 | 17,647 | 17,647 | — | 70,588 | 1,800,002 |
| Denise Zamore | PSU | 2025-04-01 | 4,902 | 4,902 | — | 19,608 | 500,004 |
| Benjamin Shaker | RSU | 2025-04-01 | — | — | 17,156 | — | 1,750,002 |
| Steven Sell | PSU | 2025-04-01 | — | 34,615 | — | 102 | 2,250,001 |
| Jeffrey Schwaneke | PSU | 2025-04-01 | — | 26,923 | — | 102 | 1,750,000 |
| Girish Venkatachaliah | PSU | 2025-04-01 | 4,289 | 4,289 | — | 17,156 | 437,502 |
| Jeffrey Schwaneke | RSU | 2025-04-01 | — | — | 17,156 | — | 1,750,002 |
| Girish Venkatachaliah | PSU | 2025-04-01 | — | 7,692 | — | 102 | 500,001 |
| Girish Venkatachaliah | RSU | 2025-04-01 | — | — | 4,902 | — | 500,004 |
| Denise Zamore | PSU | 2025-04-01 | — | 15,384 | — | 102 | 1,000,002 |
| Steven Sell | RSU | 2025-04-01 | — | — | 22,058 | — | 2,250,002 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Jeffrey Schwaneke | $1,750,002 | $2,950,001 | $0 | 62.8% |
| Benjamin Shaker | 1,750,002 | 2,950,001 | 0 | 62.8% |
| Denise Zamore | 1,000,004 | 1,500,006 | 0 | 60.0% |
| Steven Sell | 2,250,002 | 4,050,003 | 0 | 64.3% |
| Girish Venkatachaliah | 500,004 | 937,503 | 0 | 65.2% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Benjamin Shaker | RSU | 135 | — | $2,325 |
| Girish Venkatachaliah | PSU | 8,968 | — | 154,474 |
| Jeffrey Schwaneke | Option | 7,172 | 151.75 | — |
| Girish Venkatachaliah | Option | 5,535 | 111.5 | — |
| Jeffrey Schwaneke | RSU | 10,055 | — | 173,197 |
| Benjamin Shaker | RSU | 17,156 | — | 295,512 |
| Girish Venkatachaliah | RSU | 439 | — | 7,562 |
| Jeffrey Schwaneke | Option | 26,923 | 102 | — |
| Benjamin Shaker | RSU | 439 | — | 7,562 |
| Benjamin Shaker | RSU | 11,764 | — | 202,635 |
| Jeffrey Schwaneke | RSU | 6,033 | — | 103,918 |
| Girish Venkatachaliah | PSU | 4,289 | — | 73,878 |
| Girish Venkatachaliah | RSU | 108 | — | 1,860 |
| Jeffrey Schwaneke | RSU | 3,960 | — | 68,211 |
| Jeffrey Schwaneke | RSU | 10,558 | — | 181,862 |
| Girish Venkatachaliah | Option | 7,692 | 102 | — |
| Benjamin Shaker | Option | 26,923 | 102 | — |
| Jeffrey Schwaneke | RSU | 17,156 | — | 295,512 |
| Benjamin Shaker | RSU | 15,695 | — | 270,346 |
| Jeffrey Schwaneke | PSU | 11,764 | — | 202,635 |
| Girish Venkatachaliah | RSU | 4,902 | — | 84,437 |
| Benjamin Shaker | RSU | 5,886 | — | 101,386 |
| Girish Venkatachaliah | RSU | 3,363 | — | 57,928 |
| Benjamin Shaker | Option | 9,687 | 111.5 | — |
Incentive programs are designed to encourage performance and results that will create value for the Company and stockholders while avoiding unnecessary risks. Executive compensation programs have the following objectives: attract and retain top executive talent; reward executives commensurate with their performance, experience and capabilities; create a performance culture geared toward exceptional support of physician partners; and align the Company's executive interests with the interests of stockholders and incentivize executives to share in the Company's stockholder success.
| CEO STI target (% of salary) | 75% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Semler Brossy |
| Clawback policy | True |
| Anti-hedging | False |
| Anti-pledging | False |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-02 | 11,228,258 | 627,870 | 8,624 | 94.7% | Passed |
| 2025 | 2025-05-28 | 286,771,841 | 83,515,983 | 94,016 | 77.45% | Passed |
| 2024 | 2024-05-29 | 318,678,236 | 66,152,444 | 96,776 | 82.81% | Passed |
| 2023 | 2023-05-24 | 333,822,301 | 58,625,836 | 76,693 | 85.06% | Passed |
| 2022 | 2022-05-24 | 377,553,551 | 1,242,310 | 370,474 | 99.67% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-02 | 94.7%a |
| 2025 | 2025-05-28 | 77.45%b |
| 2024 | 2024-05-29 | 82.81%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 82 : 1 |
|---|---|
| CEO total compensation | $5,610,878 |
| Median employee compensation | $68,133 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Karen McLoughlinIndependent · Audit (Chair) · Compensation and Human Capital · Nominating & Governance | $95,000 | $185,005 | $0 | $0 | $0 | $280,005 |
| William Wulf, M.DIndependent · Audit · Nominating & Governance · Compliance and Quality (Chair) | 85,000 | 185,005 | 0 | 0 | 0 | 270,005 |
| Sharad Mansukani, M.DIndependent · Nominating & Governance (Chair) · Compliance and Quality | 80,000 | 185,005 | 0 | 0 | 0 | 265,005 |
| Diana L. McKenzieIndependent · Audit · Compensation and Human Capital (Chair) | 77,500 | 185,005 | 0 | 0 | 0 | 262,505 |
| Jeffrey A. SchwanekeEmployee director · Departed during FY | 70,746 | 185,005 | 0 | 0 | 0 | 255,751 |
| Silvana BattagliaIndependent · Compensation and Human Capital | 70,000 | 185,005 | 0 | 0 | 0 | 255,005 |
| Ron WilliamsNot independent · Board Chair | 0 | 185,005 | 0 | 0 | 0 | 185,005 |
| Ravi SachdevNot independent · Compliance and Quality | 0 | 0 | 0 | 0 | 0 | 0 |
| Steven J. SellEmployee director · Compliance and Quality | 0 | 0 | 0 | 0 | 0 | 0 |
| Annual cash retainer | $70,000 |
|---|---|
| Annual equity retainer | $185,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | — |
| Stock ownership guideline | 5x Annual Board Cash Retainer |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $478,246 |
| Equity awards (grant-date value) | $1,295,035 |
| All other compensation | $0 |
| Total cost of the board | $1,773,281 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies agilon health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including agilon health.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | GoodRx Holdings, Inc. | 2025 | Wendy Barnes | $825,000 | $10,921,182 | $9,000,000 | $0 | $23,367,483 |
| 2 | Doximity, Inc. | 2026 | Jeff Tangney | 627,000 | 18,955,899 | 0 | 0 | 19,586,169 |
| 3 | DaVita Inc. | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 4 | Quest Diagnostics, Inc. | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 5 | Astrana Health, Inc. | 2025 | Brandon Sim | 850,000 | 11,999,980 | 0 | 2,059,125 | 14,930,231 |
| 6 | Evolent Health, Inc. | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 7 | R1 RCM Inc. | 2023 | Lee Rivas | 900,000 | 12,240,021 | 0 | 1,015,200 | 14,159,376 |
| 8 | HealthEquity, Inc. | 2026 | Scott Cutler | 775,000 | 12,038,563 | 0 | 767,250 | 13,582,105 |
| 9 | Alignment Healthcare, Inc. | 2025 | John Kao | 833,654 | 8,500,014 | 0 | 1,944,495 | 11,278,583 |
| 10 | Teladoc Health, Inc. | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 11 | Privia Health Group, Inc. | 2025 | Parth Mehrotra | 650,000 | 8,588,373 | 0 | 1,218,750 | 10,472,698 |
| 12 | Guardant Health, Inc. | 2025 | AmirAli Talasaz | 1 | 8,647,709 | 0 | 0 | 8,661,227 |
| 13 | Progyny, Inc. | 2025 | Peter Anevski | 870,000 | 3,499,980 | 2,099,995 | 736,890 | 7,220,612 |
| 14 | Certara, Inc. | 2025 | William Feehery | 795,675 | 4,927,502 | 0 | 747,935 | 6,491,387 |
| 15 | agilon health | 2025 | Jeffrey Schwaneke | 625,000 | 2,950,003 | 1,750,000 | 271,875 | 5,610,878 |
| 16 | Veeva Systems, Inc. | 2026 | Peter Gassner | 470,833 | 0 | 0 | 0 | 470,833 |
| — | LifeStance Health Group, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| agilon health | 58% | RSU 50 · Options 50 | No | Semler Brossy |
| Alignment Healthcare, Inc. | 200% | RSU 50 · PSU 50 | No | FW Cook |
| Astrana Health, Inc. | 193.8% | PSU 67 · RSU 33 | No | Pearl Meyer |
| Certara, Inc. | 94% | PSU 60 · RSU 40 | Yes — annualized total stockholder return (ATSR) | Meridian Compensation Partners |
| DaVita Inc. | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| Doximity, Inc. | not disclosed | not disclosed | No | Aon plc (Human Capital Solutions Practice) |
| Evolent Health, Inc. | 75% | PSU 70 · RSU 30 | No | Exequity |
| GoodRx Holdings, Inc. | 60.46% | RSU 50 · Options 50 | not disclosed | Pay Governance |
| Guardant Health, Inc. | 140% | PSU 50 · RSU 50 | No | Aon |
| HealthEquity, Inc. | 99% | PSU 60 · RSU 40 | Yes | Semler Brossy |
| LifeStance Health Group, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Privia Health Group, Inc. | 150% | PSU 60 · RSU 40 | No | Korn Ferry (through September 2025), WTW (starting September 2025) |
| Progyny, Inc. | 85% | RSU 40 · Options 30 · PSU 30 | No | Semler Brossy |
| Quest Diagnostics, Inc. | not disclosed | not disclosed | not disclosed | Semler Brossy |
| R1 RCM Inc. | 94% | PSU 75 · RSU 25 | No | SullivanCotter |
| Teladoc Health, Inc. | 73% | RSU 50 · PSU 50 | No | Aon |
| Veeva Systems, Inc. | not disclosed | Options 100 | not disclosed | Compensia |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Steven Sell | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Compensation Table”. As printed: 7,278,387. Filing ↗machine: r32 · c9 · span 1662473–1662482 |
| 2 | Section 01, Jeffrey Schwaneke | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Compensation Table”. As printed: 5,610,878. Filing ↗machine: r5 · c9 · span 1591317–1591326 |
| 3 | Section 01, Benjamin Shaker | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Compensation Table”. As printed: 5,357,548. Filing ↗machine: r11 · c9 · span 1607345–1607354 |
| 4 | Section 01, Denise Zamore | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Compensation Table”. As printed: 3,123,418. Filing ↗machine: r29 · c9 · span 1653544–1653553 |
| 5 | Section 01, Girish Venkatachaliah | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Compensation Table”. As printed: 2,056,086. Filing ↗machine: r20 · c9 · span 1630762–1630771 |
| 6 | Section 03, Jeffrey Schwaneke PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r15 · c11 · span 1749150–1749159 |
| 7 | Section 03, Benjamin Shaker PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r27 · c11 · span 1773112–1773121 |
| 8 | Section 03, Benjamin Shaker PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t114 · r8 · c3 · span 1386463–1386472 |
| 9 | Section 03, Denise Zamore RSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r48 · c12 · span 1811731–1811740 |
| 10 | Section 03, Steven Sell PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r63 · c11 · span 1838639–1838648 |
| 11 | Section 03, Denise Zamore PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r51 · c8 · span 1817493–1817499 |
| 12 | Section 03, Benjamin Shaker RSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r24 · c11 · span 1766864–1766873 |
| 13 | Section 03, Steven Sell PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r57 · c9 · span 1827975–1827981 |
| 14 | Section 03, Jeffrey Schwaneke PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r9 · c9 · span 1738488–1738494 |
| 15 | Section 03, Girish Venkatachaliah PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r39 · c11 · span 1793825–1793832 |
| 16 | Section 03, Jeffrey Schwaneke RSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r12 · c11 · span 1743877–1743886 |
| 17 | Section 03, Girish Venkatachaliah PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r33 · c9 · span 1783166–1783171 |
| 18 | Section 03, Girish Venkatachaliah RSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r36 · c11 · span 1788555–1788562 |
| 19 | Section 03, Denise Zamore PSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r45 · c10 · span 1805061–1805067 |
| 20 | Section 03, Steven Sell RSU | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r60 · c11 · span 1833366–1833375 |
| 21 | Section 07, pay ratio | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “CEO Pay Ratio”. As printed: 82 : 1. Filing ↗machine: span 2512012–2512014 |
| 22 | Section 08, Karen McLoughlin | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 280,005. Filing ↗ |
| 23 | Section 08, William Wulf, M.D | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 270,005. Filing ↗ |
| 24 | Section 08, Sharad Mansukani, M.D | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 265,005. Filing ↗ |
| 25 | Section 08, Diana L. McKenzie | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 262,505. Filing ↗ |
| 26 | Section 08, Jeffrey A. Schwaneke | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 255,751. Filing ↗ |
| 27 | Section 08, Silvana Battaglia | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 255,005. Filing ↗ |
| 28 | Section 08, Ron Williams | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 185,005. Filing ↗ |
| 29 | Section 08, Ravi Sachdev | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 30 | Section 08, Steven J. Sell | DEF 14A | 2026-04-22 | 0001628280-26-026544 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 31 | Section 06, 2026 vote | Form 8-K | 2026-06-03 | 0001628280-26-040370 | Item 5.07 · say-on-pay result. As reported: 94.7% (votes for as printed: 11,228,258). Filing ↗ |
| 32 | Section 06, 2025 vote | Form 8-K | 2025-05-30 | 0001628280-25-028631 | Item 5.07 · say-on-pay result. As reported: 77.45% (votes for as printed: 286,771,841). Filing ↗ |
| 33 | Section 06, 2024 vote | Form 8-K | 2024-06-03 | 0001628280-24-026327 | Item 5.07 · say-on-pay result. As reported: 82.81% (votes for as printed: 318,678,236). Filing ↗ |
| 34 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 35 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 36 | Section 09b board cost (computed) | Computed | — | computed | Cash 478,246 + equity 1,295,035 + all other 0 = 1,773,281, summed across the director compensation table rows.machine: formula: Σ = 1,773,281 |
| 37 | GoodRx Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0001809519-26-000091 | CEO total compensation as printed in GoodRx Holdings, Inc.'s own proxy. As printed: 23,367,483. Filing ↗machine: t109 · r2 · c16 · span 1286734–1286744 |
| 38 | Doximity, Inc., Section 10b CEO total | DEF 14A | 2026-07-15 | 0001516513-26-000032 | CEO total compensation as printed in Doximity, Inc.'s own proxy. As printed: 19,586,169. Filing ↗machine: span 468084–468094 |
| 39 | DaVita Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0000927066-26-000053 | CEO total compensation as printed in DaVita Inc.'s own proxy. As printed: 18,210,597. Filing ↗machine: r2 · c45 · span 800715–800725 |
| 40 | Quest Diagnostics, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001140361-26-013356 | CEO total compensation as printed in Quest Diagnostics, Inc.'s own proxy. As printed: 15,498,479. Filing ↗machine: r2 · c17 · span 699327–699337 |
| 41 | Astrana Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001104659-26-044536 | CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. Filing ↗machine: span 525189–525199 |
| 42 | Evolent Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001193125-26-177267 | CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. Filing ↗machine: r3 · c20 · span 908544–908555 |
| 43 | R1 RCM Inc., Section 10b CEO total | DEF 14A | 2024-04-12 | 0001628280-24-015923 | CEO total compensation as printed in R1 RCM Inc.'s own proxy. As printed: 14,159,376. Filing ↗machine: span 758069–758079 |
| 44 | HealthEquity, Inc., Section 10b CEO total | DEF 14A | 2026-05-13 | 0001428336-26-000022 | CEO total compensation as printed in HealthEquity, Inc.'s own proxy. As printed: 13,582,105. Filing ↗machine: r3 · c21 · span 892475–892485 |
| 45 | Alignment Healthcare, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001628280-26-027058 | CEO total compensation as printed in Alignment Healthcare, Inc.'s own proxy. As printed: 11,278,583. Filing ↗machine: r2 · c21 · span 656828–656838 |
| 46 | Teladoc Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001477449-26-000020 | CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. Filing ↗machine: t167 · r2 · c16 · span 1057476–1057486 |
| 47 | Privia Health Group, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0001193125-26-138997 | CEO total compensation as printed in Privia Health Group, Inc.'s own proxy. As printed: 10,472,698. Filing ↗machine: t166 · r3 · c39 · span 538905–538915 |
| 48 | Guardant Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-187403 | CEO total compensation as printed in Guardant Health, Inc.'s own proxy. As printed: 8,661,227. Filing ↗machine: r7 · c31 · span 773149–773158 |
| 49 | Progyny, Inc., Section 10b CEO total | DEF 14A | 2026-04-10 | 0001551306-26-000055 | CEO total compensation as printed in Progyny, Inc.'s own proxy. As printed: 7,220,612. Filing ↗machine: r2 · c48 · span 493966–493975 |
| 50 | Certara, Inc., Section 10b CEO total | DEF 14A | 2026-04-03 | 0001104659-26-039372 | CEO total compensation as printed in Certara, Inc.'s own proxy. As printed: 6,491,387. Filing ↗machine: r1 · c42 · span 883232–883241 |
| 51 | agilon health (subject), Section 10b CEO total | DEF 14A | 2026-04-22 | 0001628280-26-026544 | CEO total compensation as printed in agilon health's own proxy. As printed: 5,610,878. Filing ↗machine: r5 · c9 · span 1591317–1591326 |
| 52 | Veeva Systems, Inc., Section 10b CEO total | DEF 14A | 2026-05-04 | 0001140361-26-018796 | CEO total compensation as printed in Veeva Systems, Inc.'s own proxy. As printed: 470,833. Filing ↗machine: t223 · r2 · c7 · span 807038–807045 |
| 53 | Section 10a, Guardant Health, Inc. reciprocity | DEF 14A | — | 0001193125-26-187403 | Guardant Health, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 54 | Section 10a, DaVita Inc. reciprocity | DEF 14A | — | 0000927066-26-000053 | DaVita Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 55 | Section 10a, Doximity, Inc. reciprocity | DEF 14A | — | 0001516513-26-000032 | Doximity, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 56 | Section 10a, Evolent Health, Inc. reciprocity | DEF 14A | — | 0001193125-26-177267 | Evolent Health, Inc. names agilon health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 57 | Section 10a, R1 RCM Inc. reciprocity | DEF 14A | — | 0001628280-24-015923 | R1 RCM Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 58 | Section 10a, Teladoc Health, Inc. reciprocity | DEF 14A | — | 0001477449-26-000020 | Teladoc Health, Inc. names agilon health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 59 | Section 10a, Progyny, Inc. reciprocity | DEF 14A | — | 0001551306-26-000055 | Progyny, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 60 | Section 10a, Quest Diagnostics, Inc. reciprocity | DEF 14A | — | 0001140361-26-013356 | Quest Diagnostics, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 61 | Section 10a, Certara, Inc. reciprocity | DEF 14A | — | 0001104659-26-039372 | Certara, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 62 | Section 10a, HealthEquity, Inc. reciprocity | DEF 14A | — | 0001428336-26-000022 | HealthEquity, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 63 | Section 10a, Privia Health Group, Inc. reciprocity | DEF 14A | — | 0001193125-26-138997 | Privia Health Group, Inc. names agilon health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 64 | Section 10a, GoodRx Holdings, Inc. reciprocity | DEF 14A | — | 0001809519-26-000091 | GoodRx Holdings, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 65 | Section 10a, Veeva Systems, Inc. reciprocity | DEF 14A | — | 0001140361-26-018796 | Veeva Systems, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. Filing ↗ |
| 66 | Section 10a, Alignment Healthcare, Inc. reciprocity | DEF 14A | — | 0001628280-26-027058 | Alignment Healthcare, Inc. names agilon health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |